Army phase i proposal A151-061-0883
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH15C0146
- Awardee
-
Xequel Bio, Inc. UEI T4JKC8B27PJ7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $149,491
Award facts
- Opportunity
-
- HQ003415R1ASB Solicitation number
- Contract value 100% obligated
- $149,491.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 111 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21702, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $49,630 | |
| Other Administrative Action | $0 | |
| Original award | $99,862 |
About this award
This is a $149,491.44 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Xequel Bio, Inc., a for-profit biomedical research and development company. The contract supports research aligned with Army medical priorities, with a focus on developing innovative solutions for battlefield trauma, medical countermeasures, and regenerative medicine. Xequel Bio has received multiple federal contracts and grants for its work in these areas, including from the National Institutes of Health, the HHS Office of the Assistant Secretary for Preparedness and Response, and the Defense Health Agency. This SBIR Phase I contract represents a competitive award to advance the development of new therapeutic candidates, diagnostics, or medical devices, with the potential for follow-on Phase II funding. The contract has a firm fixed price and an ultimate completion date of June 30, 2017.
Quick answers
Who was awarded contract W81XWH15C0146?
W81XWH15C0146 was awarded to Xequel Bio, Inc. by Medical Command (Department of the Army) on September 28, 2015.
How much is contract W81XWH15C0146 worth?
The government has obligated $149,491 on W81XWH15C0146.
Was contract W81XWH15C0146 competed?
The extent of competition for W81XWH15C0146 was full and open competition after exclusion of sources. The government received 111 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award